These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9158418)

  • 1. Recombinant cytokine treatment for scleroderma. Can the antifibrotic potential of interferon-gamma be realized clinically?
    Varga J
    Arch Dermatol; 1997 May; 133(5):637-42. PubMed ID: 9158418
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.
    Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T
    Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of the treatment of diffuse systemic scleroderma with interferon-gamma].
    Blétry O; Laraki R; Cabane J; Francès C; Piette JC; Soubrier M; Wechsler B; de Gennes C; Valat C; Cosserat J
    Rev Med Interne; 1993; 14(10):978. PubMed ID: 8009071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of systemic sclerosis with gamma-interferon.
    Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
    Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferon-gamma in the treatment of systemic sclerosis.
    Kahan A; Amor B; Menkes CJ; Strauch G
    Am J Med; 1989 Sep; 87(3):273-7. PubMed ID: 2505614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
    Vlachoyiannopoulos PG; Tsifetaki N; Dimitriou I; Galaris D; Papiris SA; Moutsopoulos HM
    Ann Rheum Dis; 1996 Oct; 55(10):761-8. PubMed ID: 8984943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with interferon gamma enhances fibrinolysis in systemic sclerosis.
    Gluszko P; Undas A; Kwasny B; Musiał J; Szczeklik A
    Thromb Res; 1998 Aug; 91(4):203-7. PubMed ID: 9736424
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Marketing. The line between scientific uncertainty and promotion of snake oil.
    Silverman E
    BMJ; 2013 Sep; 347():f5687. PubMed ID: 24055923
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the cytokine interferon gamma in clinical dermatology.
    Grassegger A; Höpfl R
    Clin Exp Dermatol; 2004 Nov; 29(6):584-8. PubMed ID: 15550127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
    Antic M; Distler JH; Distler O
    Curr Opin Pharmacol; 2013 Jun; 13(3):455-62. PubMed ID: 23747024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do the interferons have an antifibrotic action? The internist's point of view].
    Blétry O; Somogyi A
    Rev Med Interne; 2002 Nov; 23 Suppl 4():511s-515s. PubMed ID: 12481407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty on trial.
    Callaway E
    Nature; 2013 Oct; 502(7469):17-8. PubMed ID: 24091960
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant gamma interferon in psoriasis arthopathica, progressive systemic scleroderma and Behçet disease].
    Fierlbeck G; Rassner G
    Med Klin (Munich); 1988 Oct; 83(21):695-9. PubMed ID: 3148846
    [No Abstract]   [Full Text] [Related]  

  • 18. Gamma-interferon: physiology and speculation on its role in medicine.
    Bonnem EM; Oldham RK
    J Biol Response Mod; 1987 Jun; 6(3):275-301. PubMed ID: 3110378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic therapy for the treatment of pulmonary fibrosis.
    Lasky JA; Ortiz LA
    Am J Med Sci; 2001 Oct; 322(4):213-21. PubMed ID: 11678519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
    Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX
    Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.